Advertisement
Advertisement
WST
West Pharmaceutical Services, Inc.
347.61
USDSponsored
-4.69
-1.33%
Aug 13, 14:58 UTC -4
Open
WST Earnings Reports
Positive Surprise Ratio
WST beat 37 of 42 last estimates.
88%
Next Report
Date of Next Report
Oct 21, 2026
Estimate for Q3 26 (Revenue/ EPS)
$833.81M
/$2.21
Implied change from Q2 26 (Revenue/ EPS)
-4.41%
/-6.75%
Implied change from Q3 25 (Revenue/ EPS)
+3.63%
/+12.76%
West Pharmaceutical Services, Inc. earnings per share and revenue
On Jul 23, 2026, WST reported earnings of 2.37 USD per share (EPS) for Q2 26, beating the estimate of 2.10 USD, resulting in a 12.77% surprise. Revenue reached 872.30 million, compared to an expected 846.97 million, with a 2.99% difference. The market reacted with a -0.23% price change (close before vs. close after earnings).
Looking ahead to Q3 26, -- analysts forecast an EPS of 2.21 USD, with revenue projected to reach 833.81 million USD, implying an decrease of -6.75% EPS, and decrease of -4.41% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
McKesson Corporation
Report Date
Aug 05, 2026 For Q1 27
Estimate
$9.63
Actual
$9.93
Surprise
+3.11%
Cardinal Health, Inc.
Report Date
Aug 11, 2026 For Q4 26
Estimate
$2.44
Actual
$2.91
Surprise
+19.05%
Becton, Dickinson and Co.
Report Date
Aug 06, 2026 For Q3 26
Estimate
$3.17
Actual
$3.23
Surprise
+1.80%
Henry Schein Inc
Report Date
Aug 04, 2026 For Q2 26
Estimate
$1.26
Actual
$1.27
Surprise
+0.67%
Merit Medical Systems Inc
Report Date
Jul 30, 2026 For Q2 26
Estimate
$0.97
Actual
$1.19
Surprise
+21.65%
DENTSPLY SIRONA Inc.
Report Date
Aug 06, 2026 For Q2 26
Estimate
$0.35
Actual
$0.52
Surprise
+46.15%
Staar Surgical Co
Report Date
Aug 12, 2026 For Q2 26
Estimate
$0.16
Actual
$0.31
Surprise
+91.00%
FAQ
What were West Pharmaceutical Services, Inc.'s earnings and revenue for the latest quarter Q2 2026?
For Q2 2026, West Pharmaceutical Services, Inc. reported EPS of $2.37, beating estimates by 12.77%, and revenue of $872.30M, 2.99% above expectations.
How did the market react to West Pharmaceutical Services, Inc.'s Q2 2026 earnings?
The stock price moved down -0.23%, changed from $359.24 before the earnings release to $358.41 the day after.
When is West Pharmaceutical Services, Inc. expected to report next?
The next earning report is scheduled for Oct 21, 2026.
What are the forecasts for West Pharmaceutical Services, Inc.'s next earnings report?
Based on --
analysts, West Pharmaceutical Services, Inc. is expected to report EPS of $2.21 and revenue of $833.81M for Q3 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement